#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4084	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2826	401.7	0	.	n	.	0	C451T	SNP	451	451	C	1175	1175	T	593	T,C	321,134	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4084	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2826	401.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1908	1908	C	529	C	415	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6860	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3939	483.4	0	.	n	.	0	T695C	SNP	695	695	T	1190	1190	C	506	C,T,A	410,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6860	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3939	483.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1832	1832	A	555	A,G	338,99	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6860	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3939	483.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2466	2466	C	532	C,A	415,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6860	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3939	483.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2540	2540	A	543	A,C	430,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6860	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3939	483.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3092	3092	C	554	C,T	422,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6860	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3939	483.4	0	HET	.	.	.	C539T,G,A	.	539	539	C	1034	1034	C	548	C,T,G,A	302,102,1,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	554	folP	855	855	100.0	folP.l15.c4.ctg.1	1812	84.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1201	1203	AGC	109;111;112	A,C;G;C	90,1;92;92	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1318	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3886	93.9	1	SNP	p	S91F	1	.	.	271	273	TTC	793	795	TTC	86;86;85	T;T;C	64;63;64	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1318	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3886	93.9	1	SNP	p	G95N	0	.	.	283	285	GGC	805	807	GGC	88;89;90	G,C;G;C	67,1;67;66	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1318	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3886	93.9	1	SNP	p	D95G	1	.	.	283	285	GGC	805	807	GGC	88;89;90	G,C;G;C	67,1;67;66	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	566	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1617	98.7	1	SNP	p	G45D	0	.	.	133	135	GGC	574	576	GGC	167;167;167	G;G,T;C	123;128,1;125	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	346	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1358	71.8	0	.	n	.	0	A197.	DEL	197	197	A	779	779	A	156	A	121	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1524	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3522	120.9	1	SNP	p	D86N	0	.	.	256	258	GAC	870	872	GAC	154;154;154	G;A,C;C	119;117,1;123	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1524	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3522	120.9	1	SNP	p	S87R	1	.	.	259	261	CGT	873	875	CGT	153;153;153	C;G,A,T;T	120;119,1,1;112	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1524	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3522	120.9	1	SNP	p	R87W	0	.	.	259	261	CGT	873	875	CGT	153;153;153	C;G,A,T;T	120;119,1,1;112	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1524	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3522	120.9	1	SNP	p	R87I	0	.	.	259	261	CGT	873	875	CGT	153;153;153	C;G,A,T;T	120;119,1,1;112	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1524	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3522	120.9	1	SNP	p	S88P	0	.	.	262	264	TCC	876	878	TCC	153;154;154	T;C;C	115;125;123	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1052	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2919	101.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1687	1689	GGC	126;126;127	G;G;C,G	101;99;98,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1490	1492	GCC	142;142;142	G;C;C	113;111;114	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1493	1495	ATG	143;143;144	A;T;G	114;114;116	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1505	1507	ACC	143;143;145	A;C;C	113;112;113	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1505	1507	ACC	143;143;145	A;C;C	113;112;113	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2006	2008	ACC	115;114;114	A,C;C;C,A	91,1;88;89,1	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2060	2062	GCG	131;131;131	G,T;C,G;G	95,1;94,1;94	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2060	2062	GCG	131;131;131	G,T;C,G;G	95,1;94,1;94	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2183	2185	GGT	134;134;135	G;G,C;T	105;103,1;104	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2192	2194	AGC	134;134;136	A;G;C	101;107;107	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	984	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2790	98.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2210	2212	CCG	135;135;135	C;C;G	101;102;103	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1390	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3583	107.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1923	1925	CCG	120;120;119	C;C;G	94;92;90	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	604	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2066	81.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	690	690	C	90	C	71	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1176	1178	AAT	3;3;3	A;A;T	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1179	1181	AAT	3;3;3	A;A;T	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1203	1205	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1227	1228	TC	2;2	T;C	2;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1232	1234	AAC	2;2;2	A;A;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1236	1240	TGGCG	2;2;2;2;2	T;G;G;C;G	2;2;2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1242	1244	GCT	2;2;2	G;C;T	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1302	1304	TTA	2;2;2	T;T;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1347	1349	CAT	5;5;5	C;A;T	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1350	1352	AGT	5;5;5	A;G;T	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	294	90.6	porB1a.l15.c4.ctg.1	1445	19.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1359	1361	TAC	5;5;5	T;A;C	3;3;3	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	910	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1920	129.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	652	654	GAA	186;186;185	G;A;A	140;143;144	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	910	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1920	129.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1063	1065	TCA	143;141;141	T;C;A	114;117;117	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	910	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1920	129.8	0	.	p	.	0	Y254S	NONSYN	760	762	TAT	1300	1302	TCT	146;146;146	T;C;T	116;113;116	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	910	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1920	129.8	1	SNP	p	G120K	1	.	.	358	360	AAG	898	900	AAG	167;167;167	A,C;A;G	122,1;126;127	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	910	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1920	129.8	1	SNP	p	A121D	1	.	.	361	363	GAC	901	903	GAC	167;168;168	G;A,T;C,A	126;126,1;123,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	910	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1920	129.8	1	SNP	p	D121N	0	.	.	361	363	GAC	901	903	GAC	167;168;168	G;A,T;C,A	126;126,1;123,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2748	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5372	143.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	430	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1427	85.7	1	SNP	p	V57M	1	.	.	169	171	ATG	714	716	ATG	177;178;179	A;T;G	145;147;148	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
